Biocon shares in focus today as US FDA issues four observations for insulin facility : vimarsana.com

Biocon stock ended 2.05% higher at Rs 276.50 on Thursday against the previous close of Rs 270.95 on BSE. The stock touched an intraday high of Rs 277.60 .

Related Keywords

United States , Biocon Biologics , Drug Administration , Biocon Biologics Limited Campus Site , Biocon , Biocon Ltd , United States Food , Biocon Biologics Limited , Biocon Campus , Drug Substance , Pre Approval Supplement , Preventive Action ,